A carregar...
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients
BACKGROUND: Nivolumab is an anti–PD-1 antibody that restores the antitumour immune function of T cells, blocking the binding of PD-1 with its ligand PD-L1. PD-1 is expressed on T cells and interacts with PD-L1 on tumour cells. The PD-1–PD-L1 link inhibits T cell activation. In metastatic melanoma, P...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253741/ https://ncbi.nlm.nih.gov/pubmed/32489255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5293 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|